1728 related articles for article (PubMed ID: 26178901)
1. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).
Hannafon BN; Carpenter KJ; Berry WL; Janknecht R; Dooley WC; Ding WQ
Mol Cancer; 2015 Jul; 14():133. PubMed ID: 26178901
[TBL] [Abstract][Full Text] [Related]
2. Docosahexaenoic acid (DHA) inhibits pro-angiogenic effects of breast cancer cells via down-regulating cellular and exosomal expression of angiogenic genes and microRNAs.
Aslan C; Maralbashi S; Kahroba H; Asadi M; Soltani-Zangbar MS; Javadian M; Shanehbandi D; Baradaran B; Darabi M; Kazemi T
Life Sci; 2020 Oct; 258():118094. PubMed ID: 32673663
[TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic acid reverses the promoting effects of breast tumor cell-derived exosomes on endothelial cell migration and angiogenesis.
Ghaffari-Makhmalbaf P; Sayyad M; Pakravan K; Razmara E; Bitaraf A; Bakhshinejad B; Goudarzi P; Yousefi H; Pournaghshband M; Nemati F; Fahimi H; Rohollah F; Hasanzad M; Hashemi M; Mousavi SH; Babashah S
Life Sci; 2021 Jan; 264():118719. PubMed ID: 33159957
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
[TBL] [Abstract][Full Text] [Related]
5. Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer.
Bovy N; Blomme B; Frères P; Dederen S; Nivelles O; Lion M; Carnet O; Martial JA; Noël A; Thiry M; Jérusalem G; Josse C; Bours V; Tabruyn SP; Struman I
Oncotarget; 2015 Apr; 6(12):10253-66. PubMed ID: 25860935
[TBL] [Abstract][Full Text] [Related]
6. Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells.
Wang X; Huang W; Liu G; Cai W; Millard RW; Wang Y; Chang J; Peng T; Fan GC
J Mol Cell Cardiol; 2014 Sep; 74():139-50. PubMed ID: 24825548
[TBL] [Abstract][Full Text] [Related]
7. Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer.
Singh R; Pochampally R; Watabe K; Lu Z; Mo YY
Mol Cancer; 2014 Nov; 13():256. PubMed ID: 25428807
[TBL] [Abstract][Full Text] [Related]
8. Plasma exosome microRNAs are indicative of breast cancer.
Hannafon BN; Trigoso YD; Calloway CL; Zhao YD; Lum DH; Welm AL; Zhao ZJ; Blick KE; Dooley WC; Ding WQ
Breast Cancer Res; 2016 Sep; 18(1):90. PubMed ID: 27608715
[TBL] [Abstract][Full Text] [Related]
9. Angiogenic role of miR-20a in breast cancer.
Luengo-Gil G; Gonzalez-Billalabeitia E; Perez-Henarejos SA; Navarro Manzano E; Chaves-Benito A; Garcia-Martinez E; Garcia-Garre E; Vicente V; Ayala de la Peña F
PLoS One; 2018; 13(4):e0194638. PubMed ID: 29617404
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J
Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641
[TBL] [Abstract][Full Text] [Related]
11. The repressive effect of miR-148a on Wnt/β-catenin signaling involved in Glabridin-induced anti-angiogenesis in human breast cancer cells.
Mu J; Zhu D; Shen Z; Ning S; Liu Y; Chen J; Li Y; Li Z
BMC Cancer; 2017 May; 17(1):307. PubMed ID: 28464803
[TBL] [Abstract][Full Text] [Related]
12. High concentrations of uric acid inhibit angiogenesis via regulation of the Krüppel-like factor 2-vascular endothelial growth factor-A axis by miR-92a.
Yu S; Hong Q; Wang Y; Hou K; Wang L; Zhang Y; Fu B; Zhou Y; Zheng W; Chen X; Wu D
Circ J; 2015; 79(11):2487-98. PubMed ID: 26299712
[TBL] [Abstract][Full Text] [Related]
13. Annexin-A1 regulates microRNA-26b* and microRNA-562 to directly target NF-κB and angiogenesis in breast cancer cells.
Anbalagan D; Yap G; Yuan Y; Pandey VK; Lau WH; Arora S; Bist P; Wong JS; Sethi G; Nissom PM; Lobie PE; Lim LH
PLoS One; 2014; 9(12):e114507. PubMed ID: 25536365
[TBL] [Abstract][Full Text] [Related]
14. Visualization of exosome-mediated miR-210 transfer from hypoxic tumor cells.
Jung KO; Youn H; Lee CH; Kang KW; Chung JK
Oncotarget; 2017 Feb; 8(6):9899-9910. PubMed ID: 28038441
[TBL] [Abstract][Full Text] [Related]
15. Metastasis-associated protein 1 (MTA1) is transferred by exosomes and contributes to the regulation of hypoxia and estrogen signaling in breast cancer cells.
Hannafon BN; Gin AL; Xu YF; Bruns M; Calloway CL; Ding WQ
Cell Commun Signal; 2019 Feb; 17(1):13. PubMed ID: 30782165
[TBL] [Abstract][Full Text] [Related]
16. Regulation of RAB22A by mir-193b inhibits breast cancer growth and metastasis mediated by exosomes.
Sun L; He M; Xu N; Xu DH; Ben-David Y; Yang ZY; Li YJ
Int J Oncol; 2018 Dec; 53(6):2705-2714. PubMed ID: 30272274
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayers.
Di Modica M; Regondi V; Sandri M; Iorio MV; Zanetti A; Tagliabue E; Casalini P; Triulzi T
Cancer Lett; 2017 Jan; 384():94-100. PubMed ID: 27693459
[TBL] [Abstract][Full Text] [Related]
18. Exosomal EPHA2 derived from highly metastatic breast cancer cells promotes angiogenesis by activating the AMPK signaling pathway through Ephrin A1-EPHA2 forward signaling.
Han B; Zhang H; Tian R; Liu H; Wang Z; Wang Z; Tian J; Cui Y; Ren S; Zuo X; Tian R; Niu R; Zhang F
Theranostics; 2022; 12(9):4127-4146. PubMed ID: 35673569
[No Abstract] [Full Text] [Related]
19. Exosome-mediated miR-222 transferring: An insight into NF-κB-mediated breast cancer metastasis.
Ding J; Xu Z; Zhang Y; Tan C; Hu W; Wang M; Xu Y; Tang J
Exp Cell Res; 2018 Aug; 369(1):129-138. PubMed ID: 29778754
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cells require miR-214 to secrete exosomes that suppress senescence and induce angiogenesis in human and mouse endothelial cells.
van Balkom BW; de Jong OG; Smits M; Brummelman J; den Ouden K; de Bree PM; van Eijndhoven MA; Pegtel DM; Stoorvogel W; Würdinger T; Verhaar MC
Blood; 2013 May; 121(19):3997-4006, S1-15. PubMed ID: 23532734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
